Amyloidosis Foundation
Amyloidosis Foundation maintains stable finances and zero reported officer compensation over a decade.
EIN: 200291856 · Clarkston, MI · NTEE: H25 · Updated: 2026-03-28
Is Amyloidosis Foundation Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Amyloidosis Foundation directs 85% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Amyloidosis Foundation
Amyloidosis Foundation (EIN: 200291856) is a nonprofit organization based in Clarkston, MI, classified under NTEE code H25. The organization reported total revenue of $1.0M and total assets of $1.1M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Amyloidosis Foundation's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Amyloidosis Foundation with a Mission Score of 90 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 85%
- fundraising: 5%
According to IRS 990 filings, Amyloidosis Foundation allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.
Executive Compensation Analysis
Executive compensation is reported as 0% across all available filings, indicating that the organization's leadership is either entirely volunteer-based or compensated through non-officer roles, which is highly efficient for an organization with over $1 million in assets.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Amyloidosis Foundation's IRS 990 filings:
- Fluctuating annual revenue, with a notable decrease from $779,248 in 2021 to $535,162 in 2023, could indicate potential challenges in consistent fundraising or donor retention.
Strengths
The following positive indicators were identified for Amyloidosis Foundation:
- Zero reported officer compensation across all 14 filings, indicating highly efficient use of funds.
- Consistent growth in assets, from $612,000 in 2016 to over $1 million in recent years, demonstrating strong financial management and reserve building.
- Low liabilities relative to assets, indicating a healthy balance sheet and minimal debt.
- Long history of consistent IRS 990 filings (14 filings), demonstrating strong transparency and accountability.
Frequently Asked Questions about Amyloidosis Foundation
Is Amyloidosis Foundation a legitimate charity?
Based on AI analysis of IRS 990 filings, Amyloidosis Foundation (EIN: 200291856) some concerns. Mission Score: 90/100. 1 red flag identified, 4 strengths noted.
How does Amyloidosis Foundation spend its money?
Amyloidosis Foundation directs 85% of its spending to programs and services. The remaining budget covers administration and fundraising costs.
Are donations to Amyloidosis Foundation tax-deductible?
Amyloidosis Foundation is registered as a tax-exempt nonprofit (EIN: 200291856). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Is the Amyloidosis Foundation a good charity?
Based on the provided data, the Amyloidosis Foundation appears to be a good charity. It demonstrates strong financial stability with growing assets, consistent IRS 990 filings, and notably, zero reported officer compensation, suggesting a highly efficient use of donor funds for its mission.
How has the organization's revenue trended over the last few years?
The organization's revenue has fluctuated in recent years, decreasing from $779,248 in 2021 to $535,162 in 2023, though it was $710,435 in 2022. This indicates some variability in annual income.
What is the financial stability of the Amyloidosis Foundation?
The Amyloidosis Foundation shows strong financial stability, consistently maintaining assets well over $1 million in recent years ($1,050,511 in 2023) and keeping liabilities very low (e.g., $4,622 in 2023). This indicates a healthy balance sheet and good financial management.
Filing History
IRS 990 filing history for Amyloidosis Foundation showing financial trends over 14 years of public records:
Over 14 years of IRS 990 filings (2010–2023), Amyloidosis Foundation's revenue has grown by 19.5%, moving from $448K to $535K. Total assets increased by 90.8% over the same period, from $551K to $1.1M. Total functional expenses rose by 82.9%, from $311K to $569K. In its most recent filing year (2023), Amyloidosis Foundation reported a deficit of $34K, with expenses exceeding revenue. The organization holds $5K in liabilities against $1.1M in assets (debt-to-asset ratio: 0.4%), resulting in net assets of $1.0M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. | |
|---|---|---|---|---|---|---|
| 2023 | $535K | $569K | $1.1M | $5K | — | — |
| 2022 | $710K | $598K | $1.1M | $21K | — | — |
| 2021 | $779K | $709K | $1.1M | $8K | — | View 990 |
| 2020 | $694K | $592K | $951K | $10K | — | — |
| 2019 | $738K | $684K | $757K | $16K | — | View 990 |
| 2018 | $661K | $625K | $665K | $3K | — | View 990 |
| 2017 | $844K | $810K | $690K | $5K | — | View 990 |
| 2016 | $704K | $730K | $612K | $2K | — | View 990 |
| 2015 | $579K | $828K | $662K | $50K | — | View 990 |
| 2014 | $861K | $509K | $855K | $12K | — | View 990 |
| 2013 | $457K | $358K | $493K | $2K | — | View 990 |
| 2012 | $426K | $465K | $393K | $24K | — | View 990 |
| 2011 | $335K | $449K | $408K | $0 | — | View 990 |
| 2010 | $448K | $311K | $551K | $0 | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $535K, expenses of $569K, and assets of $1.1M (revenue -24.7% year-over-year).
- 2022: Revenue of $710K, expenses of $598K, and assets of $1.1M (revenue -8.8% year-over-year).
- 2021: Revenue of $779K, expenses of $709K, and assets of $1.1M (revenue +12.3% year-over-year).
- 2020: Revenue of $694K, expenses of $592K, and assets of $951K (revenue -5.9% year-over-year).
- 2019: Revenue of $738K, expenses of $684K, and assets of $757K (revenue +11.6% year-over-year).
- 2018: Revenue of $661K, expenses of $625K, and assets of $665K (revenue -21.7% year-over-year).
- 2017: Revenue of $844K, expenses of $810K, and assets of $690K (revenue +19.9% year-over-year).
- 2016: Revenue of $704K, expenses of $730K, and assets of $612K (revenue +21.6% year-over-year).
- 2015: Revenue of $579K, expenses of $828K, and assets of $662K (revenue -32.8% year-over-year).
- 2014: Revenue of $861K, expenses of $509K, and assets of $855K (revenue +88.6% year-over-year).
- 2013: Revenue of $457K, expenses of $358K, and assets of $493K (revenue +7.3% year-over-year).
- 2012: Revenue of $426K, expenses of $465K, and assets of $393K (revenue +27.2% year-over-year).
- 2011: Revenue of $335K, expenses of $449K, and assets of $408K (revenue -25.3% year-over-year).
- 2010: Revenue of $448K, expenses of $311K, and assets of $551K.
Data Sources and Methodology
This transparency report for Amyloidosis Foundation is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.